BioScrip to Host Third Quarter 2008 Earnings Call

Business Wire, Oct 20, 2008

ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS) announced today that it will release its third quarter 2008 financial results before the market opens on Tuesday, November 4, 2008, and host a conference call shortly thereafter at 10:30 AM (ET) to discuss the results for the period ended September 30, 2008. Richard H. Friedman, Chairman and Chief Executive Officer, and Stanley G. Rosenbaum, Executive Vice President and Chief Financial Officer, will host the call.

Interested parties may participate in the conference call by dialing 800-954-1053 (US), or 212-231-2901 (International), 5-10 minutes prior to the start of the call. A replay of the conference call will be available from 12:00 p.m. ET on November 4, through 12:00 p.m. ET on November 11, by dialing 800-633-8284 (US), or 1-402-977-9140 (International), and entering reservation #21397034. An audio web cast and archive of the conference call will also be available under the investor relations section of the BioScrip website, www.bioscrip.com.

About BioScrip, Inc.

BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payors and pharmaceutical manufacturers to provide access to medications and management solutions to optimize outcomes for chronic and other complex healthcare conditions.

Forward Looking Statements

This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company and our success with respect to the integration and consolidation. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.